A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.

Clinical trial NCT07011485 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07011485
Sponsor: PDFE Pharma Innovations FZCO
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alopecia, Androgenetic Baldness Androgenetic Alopecia (AGA)

Start date: 2025-05-14
Primary completion: 2025-08-14
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.